Similar articles for PMID: 23870722

Year	Number of Results
1989	1
1993	1
1994	1
1995	1
2000	1
2001	1
2003	2
2004	2
2005	2
2006	4
2007	6
2008	4
2009	3
2010	5
2011	11
2012	8
2013	14
2014	16
2015	20
2016	16
2017	18
2018	20
2019	11
2020	9
2021	3

1

Omega-3 fatty acid supplementation in adolescents with borderline personality disorder and ultra-high risk criteria for psychosis: a post hoc subgroup analysis of a double-blind, randomized controlled trial.

Amminger GP, Chanen AM, Ohmann S, Klier CM, Mossaheb N, Bechdolf A, Nelson B, Thompson A, McGorry PD, Yung AR, Schäfer MR. Amminger GP, et al. Can J Psychiatry. 2013 Jul;58(7):402-8. doi: 10.1177/070674371305800705. Can J Psychiatry. 2013. PMID: 23870722 Clinical Trial.

2

Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial.

Amminger GP, Schäfer MR, Papageorgiou K, Klier CM, Cotton SM, Harrigan SM, Mackinnon A, McGorry PD, Berger GE. Amminger GP, et al. Arch Gen Psychiatry. 2010 Feb;67(2):146-54. doi: 10.1001/archgenpsychiatry.2009.192. Arch Gen Psychiatry. 2010. PMID: 20124114 Clinical Trial.

3

Effect of ω-3 Polyunsaturated Fatty Acids in Young People at Ultrahigh Risk for Psychotic Disorders: The NEURAPRO Randomized Clinical Trial.

McGorry PD, Nelson B, Markulev C, Yuen HP, Schäfer MR, Mossaheb N, Schlögelhofer M, Smesny S, Hickie IB, Berger GE, Chen EY, de Haan L, Nieman DH, Nordentoft M, Riecher-Rössler A, Verma S, Thompson A, Yung AR, Amminger GP. McGorry PD, et al. JAMA Psychiatry. 2017 Jan 1;74(1):19-27. doi: 10.1001/jamapsychiatry.2016.2902. JAMA Psychiatry. 2017. PMID: 27893018 Free article. Clinical Trial.

4

Predictors of treatment response in young people at ultra-high risk for psychosis who received long-chain omega-3 fatty acids.

Amminger GP, Mechelli A, Rice S, Kim SW, Klier CM, McNamara RK, Berk M, McGorry PD, Schäfer MR. Amminger GP, et al. Transl Psychiatry. 2015 Jan 13;5(1):e495. doi: 10.1038/tp.2014.134. Transl Psychiatry. 2015. PMID: 25585167 Free PMC article. Clinical Trial.

5

Supplementation of n-3 Polyunsaturated Fatty Acids for Major Depressive Disorder: A Randomized, Double-Blind, 12-Week, Placebo-Controlled Trial in Korea.

Park Y, Park YS, Kim SH, Oh DH, Park YC. Park Y, et al. Ann Nutr Metab. 2015;66(2-3):141-8. doi: 10.1159/000377640. Epub 2015 Mar 24. Ann Nutr Metab. 2015. PMID: 25824637 Clinical Trial.

6

Effect of omega-3 fatty acids for indicated prevention of young patients at risk for psychosis: when do they begin to be effective?

Mossaheb N, Schäfer MR, Schlögelhofer M, Klier CM, Cotton SM, McGorry PD, Amminger GP. Mossaheb N, et al. Schizophr Res. 2013 Aug;148(1-3):163-7. doi: 10.1016/j.schres.2013.05.027. Epub 2013 Jun 15. Schizophr Res. 2013. PMID: 23778032 Clinical Trial.

7

Omega-3 fatty acid supplementation changes intracellular phospholipase A2 activity and membrane fatty acid profiles in individuals at ultra-high risk for psychosis.

Smesny S, Milleit B, Hipler UC, Milleit C, Schäfer MR, Klier CM, Holub M, Holzer I, Berger GE, Otto M, Nenadic I, Berk M, McGorry PD, Sauer H, Amminger GP. Smesny S, et al. Mol Psychiatry. 2014 Mar;19(3):317-24. doi: 10.1038/mp.2013.7. Epub 2013 Mar 12. Mol Psychiatry. 2014. PMID: 23478748 Clinical Trial.

8

A dose comparison of olanzapine for the treatment of borderline personality disorder: a 12-week randomized, double-blind, placebo-controlled study.

Zanarini MC, Schulz SC, Detke HC, Tanaka Y, Zhao F, Lin D, Deberdt W, Kryzhanovskaya L, Corya S. Zanarini MC, et al. J Clin Psychiatry. 2011 Oct;72(10):1353-62. doi: 10.4088/JCP.08m04138yel. J Clin Psychiatry. 2011. PMID: 21535995 Clinical Trial.

9

omega-3 Fatty acid treatment of women with borderline personality disorder: a double-blind, placebo-controlled pilot study.

Zanarini MC, Frankenburg FR. Zanarini MC, et al. Am J Psychiatry. 2003 Jan;160(1):167-9. doi: 10.1176/appi.ajp.160.1.167. Am J Psychiatry. 2003. PMID: 12505817 Clinical Trial.

10

A randomized clinical trial of high eicosapentaenoic acid omega-3 fatty acids and inositol as monotherapy and in combination in the treatment of pediatric bipolar spectrum disorders: a pilot study.

Wozniak J, Faraone SV, Chan J, Tarko L, Hernandez M, Davis J, Woodworth KY, Biederman J. Wozniak J, et al. J Clin Psychiatry. 2015 Nov;76(11):1548-55. doi: 10.4088/JCP.14m09267. J Clin Psychiatry. 2015. PMID: 26646031 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed